Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06043427
Title Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN

Facility Status City State Zip Country Details
Tom Baker Cancer Centre NOT_YET_RECRUITING Calgary Alberta T2N 4N2 Canada Details
BCCA - Vancouver NOT_YET_RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
CancerCare Manitoba RECRUITING Winnipeg Manitoba R3E 0V9 Canada Details
QEII Health Sciences Centre NOT_YET_RECRUITING Halifax Nova Scotia B3H 1V7 Canada Details
Kingston Health Sciences Centre RECRUITING Kingston Ontario K7L 2V7 Canada Details
Grand River Regional Cancer Centre RECRUITING Kitchener Ontario N2G 1G3 Canada Details
Verspeeten Family Cancer Centre RECRUITING London Ontario N6A 5W9 Canada Details
Lakeridge Health Oshawa RECRUITING Oshawa Ontario L1G 2B9 Canada Details
Ottawa Hospital Research Institute RECRUITING Ottawa Ontario K1H 8L6 Canada Details
Odette Cancer Centre RECRUITING Toronto Ontario M4N 3M5 Canada Details
St. Michael's Hospital RECRUITING Toronto Ontario M5B 1W8 Canada Details
University Health Network RECRUITING Toronto Ontario M5G 2M9 Canada Details
CHUM-Centre Hospitalier de l'Universite de Montreal NOT_YET_RECRUITING Montreal Quebec H2X 3E4 Canada Details
Allan Blair Cancer Centre RECRUITING Regina Saskatchewan S4T 7T1 Canada Details
Saskatoon Cancer Centre RECRUITING Saskatoon Saskatchewan S7N 4H4 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field